Entering text into the input field will update the search result below

Sorrento reports results of Covistix and Panbio antigen rapid tests for COVID-19 detection

Coronavirus and DNA, virus mutation. New variant and strain of SARS CoV 2. Microscopic view.
Gilnature/iStock via Getty Images

  • Sorrento Therapeutics (NASDAQ:SRNE) announces impressive results from an independent study conducted under real-world field conditions by INMEGEN (The Institute of National Genomics Medicine, Mexico).
  • The objective of the study was to evaluate the performance and

Recommended For You

About SRNEQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SRNEQ--
Sorrento Therapeutics, Inc.